Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
Instagram Outage Disrupts Thousands of U.S. Users 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
The Apple Watch is expected to feature important health monitoring features that could provide blood pressure and blood sugar information. However, a new report says its development has faced some issues, and they are not expected to become available in the next few years.
Every year, in anticipation of a new Apple Watch, advanced health monitoring features are commonly mentioned in reports. But Bloomberg's Mark Gurman reports that the smartwatch's capability to track blood pressure is unlikely to launch until 2024 "at the earliest."
Sources of Gurman said the development of the blood pressure monitoring for the Apple Watch has faced some issues with accuracy during testing that led to its delay. While its launch is possible in the next two years, the same report said the timeframe could still extend to 2025.
Apple is said to be testing the Apple Watch blood pressure monitor on its employees, and its implementation could be different from Samsung's blood pressure detection. Newer Galaxy Watch models provide specific systolic and diastolic readings, but users need to calibrate the device every four weeks by manually entering blood pressure readings after using a conventional monitoring cuff. Apple's version is not expected to provide specific readings, but the report says future Apple Watches may issue warnings if the user potentially has hypertension and if they need to consult a doctor.
Meanwhile, Apple Watch fans might have to wait longer for the non-invasive blood sugar monitoring function. Gurman said this health feature does not even have a release timeline yet, but it is "still several years away" from launch.
Apple, however, is still expected to introduce new health features sooner, including the body temperature sensor that could launch with the 2022 Apple Watch. Its first version is expected to focus on fertility and family planning, but the report said its use could be expanded to let users know if their body temperature is higher than normal.
The report also mentioned an anticipated improvement in the Apple Watch's low-power mode through watchOS 9. The update could allow users to access more apps and features even when they enable the Power Reserve setting. watchOS 9 will be one of the main announcements in the upcoming WWDC that will kick off on June 6.
Photo by Onur Binay on Unsplash
